The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Irish Pharmaceutical Healthcare Association .

Filed returns
182
match these filters
Matching filed returns per period 0 5 10 15 20 Sep–Dec 2015: 5 filed returns Jan–Apr 2016: 2 filed returns May–Aug 2016: 2 filed returns Sep–Dec 2016: 3 filed returns Jan–Apr 2017: 3 filed returns May–Aug 2017: 4 filed returns Sep–Dec 2017: 8 filed returns Jan–Apr 2018: 5 filed returns May–Aug 2018: 5 filed returns Sep–Dec 2018: 11 filed returns Jan–Apr 2019: 7 filed returns May–Aug 2019: 8 filed returns Sep–Dec 2019: 4 filed returns Jan–Apr 2020: 4 filed returns May–Aug 2020: 5 filed returns Sep–Dec 2020: 2 filed returns Jan–Apr 2021: 6 filed returns May–Aug 2021: 4 filed returns Sep–Dec 2021: 2 filed returns Jan–Apr 2022: 1 filed returns May–Aug 2022: 8 filed returns Sep–Dec 2022: 7 filed returns Jan–Apr 2023: 4 filed returns May–Aug 2023: 5 filed returns Sep–Dec 2023: 3 filed returns Jan–Apr 2024: 4 filed returns May–Aug 2024: 4 filed returns Sep–Dec 2024: 8 filed returns Jan–Apr 2025: 18 filed returns May–Aug 2025: 11 filed returns Sep–Dec 2025: 7 filed returns Jan–Apr 2026: 6 filed returns May–Aug 2026: 6 filed returns 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Jan–Apr 2021 Irish Pharmaceutical Healthcare Association Health Treatment Abroad Scheme and Cell Gene Therapies (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2021 Irish Pharmaceutical Healthcare Association Health EU Pharmaceutical Strategy (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2021 Irish Pharmaceutical Healthcare Association Health Access to new medicines (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2021 Irish Pharmaceutical Healthcare Association Health Extension of framework agreement on medicines. (Public policy or programme) 14 On lobbying.ie
Sep–Dec 2020 Irish Pharmaceutical Healthcare Association Health Readiness of Ireland to produce and provide cell and gene therapies (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2020 Irish Pharmaceutical Healthcare Association Health Potential for new IPHA Medicines Supply Agreement (Public policy or programme) 2 On lobbying.ie
May–Aug 2020 Irish Pharmaceutical Healthcare Association Health Government policy on access to new medicines (Public policy or programme) 3 On lobbying.ie
May–Aug 2020 Irish Pharmaceutical Healthcare Association Health Establishment of National Medicines Agency (Public policy or programme) 1 On lobbying.ie
May–Aug 2020 Irish Pharmaceutical Healthcare Association Health Interaction between DPER and DoH/HSE on funding for new medicines (Public policy or programme) 1 On lobbying.ie
May–Aug 2020 Irish Pharmaceutical Healthcare Association Health New Framework Agreement between the State and IPHA on supply of medicines (Public policy or programme) 1 On lobbying.ie
May–Aug 2020 Irish Pharmaceutical Healthcare Association Health Medicines Policy and Programme for Government (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2020 Irish Pharmaceutical Healthcare Association Health Importance of a definitive and focused medicines policy, especially regarding access, in the Programme for Government (Public policy or programme) 12 On lobbying.ie
Jan–Apr 2020 Irish Pharmaceutical Healthcare Association Health Directive on Best Value Biologics (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2020 Irish Pharmaceutical Healthcare Association Health Importance of medicines policy in General Election dialogue (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2020 Irish Pharmaceutical Healthcare Association Health Operation of current Medicines Supply Agreement and planning for successor agreement (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2019 Irish Pharmaceutical Healthcare Association Health New medicines Supply Agreement with State (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2019 Irish Pharmaceutical Healthcare Association Health Report commissioned by Department of Health from Mazars on drug reimbursement system (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2019 Irish Pharmaceutical Healthcare Association Health State spend on medicines in hospitals 2015 to 2018 (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2019 Irish Pharmaceutical Healthcare Association Health New Supply Agreement and State vaccines group (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health IPHA approach to new supply agreement and current policy provisions (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health PwC report for EFPIA on value of pharmaceutical industry (Public policy or programme) 11 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health Health Committee hearings on medicines (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health IPHA Manifesto for Better Health (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health Government policy on access to new medicines (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health Prescriber incentives for biosimilars (Public policy or programme) 2 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health World Health Assembly - Italian proposal on pharmacuticals (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Irish Pharmaceutical Healthcare Association Health Official policy on biologics (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health Policy Forum for Ireland’s BioPharma Future and ‘BioPharma Ambition 2020 (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health Manifesto of the European Federation of Pharmaceutical Industries and Associations (EFPIA) for the European elections (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health EU draft legislation to alter IP protections for pharmaceutical industry (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health To highlight importance of continuity of supply of medicines in Europe post Brexit (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health IPHA policy document "Manifesto for Better Health" (Public policy or programme) 14 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health Proposed dialogue between industry and State on an improved reimbursement system for medicines (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2019 Irish Pharmaceutical Healthcare Association Health Originator pharmaceutical industry's preparations for Brexit (Public policy or programme) 9 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Impact of Brexit on medicines supply (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Private members bill to amend Health Act and introduce a separate reimbursement process for orphan drugs (Legislation) 1 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Medicine pricing (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health IPHA 'Manifesto for Better Health' (Public policy or programme) 25 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Irish Government Economic and Evaluation Service (IGEES) policy forum on drug costs (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Inclusion of medicine regulation in Brexit withdrawal agreement (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health IPHA member companies preparation for Brexit (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Inclusion of IPHA position on access to innovative medicines in discussions on renewal of Confidence and Supply Agreement (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health EU Commission proposals to introduce an SPC waiver on pharmaceutical products (Public policy or programme) 6 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health Liaison with Deputy Dara Calleary regarding the reimbursement status of Spinraza (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Irish Pharmaceutical Healthcare Association Health To advise the Fianna Fail Spokesperson on Health and members of the joint Oireachtas Committee on Health of IPHA concerns on a private members bill to amend the Health (Pricing and Supply of Medical Goods) Act 2013 (Public policy or programme) 11 On lobbying.ie
May–Aug 2018 Irish Pharmaceutical Healthcare Association Health To arrange briefing meetings with Government Special Advisors (Public policy or programme) 6 On lobbying.ie
May–Aug 2018 Irish Pharmaceutical Healthcare Association Health EU legislative proposal to introduce an SPC waiver on pharmaceutical products (Public policy or programme) 2 On lobbying.ie
May–Aug 2018 Irish Pharmaceutical Healthcare Association Health Briefing of Fianna Fáil Deputy Leader and Director of Policy, Dara Calleary, TD (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Irish Pharmaceutical Healthcare Association Health Briefing of Fianna Fáil Spokesperson on Health, Stephen Donnelly TD (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Irish Pharmaceutical Healthcare Association Health IPHA political series with Health spokespersons (Public policy or programme) 5 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 182 100.0%